NewEdge Advisors’s Axonics, Inc. Common Stock AXNX Stock Holding History

NewEdge Advisors’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-115	Closed	-$7.19K	–	4241
2022 Q4	$7.19K	Buy	+115	New	+$7.63K	﹤0.01%	2468

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

NewEdge Advisors's AXNX Position: Q1 2023 in Review

NewEdge Advisors sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2023, closing a stake of 115 shares — an estimated $7.19K sold.

NewEdge Advisors first reported a position in AXNX in Q4 2022 and held it in 1 quarter. The position peaked at $7.19K in Q4 2022. 236 funds tracked by Wall St. Rank hold AXNX as of Q1 2023.

NewEdge Advisors reported no remaining Axonics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
NewEdge Advisors sold 115 Axonics, Inc. Common Stock shares in Q1 2023, an estimated $7.19K.
NewEdge Advisors first reported a position in Axonics, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
NewEdge Advisors's Axonics, Inc. Common Stock position peaked at $7.19K in Q4 2022.
236 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2023.

Based on NewEdge Advisors's 13F filing for Q1 2023, filed 12 May 2023.